Dear Stakeholders

Contributing to Society through Healthcare

  • Takayoshi Mimura
    Chairman of the Board
  • Shinjiro Sato
    President and CEO

We want to first express our heartfelt condolences for those who have passed away due to COVID-19, and our wishes for a speedy recovery to those who have become ill from it.

Terumo Group will continue to prioritize the health and safety of all associates, while focusing our combined energy on providing a stable supply of products and services that sustain healthcare, and actively engaging in the prevention and treatment of COVID-19.

Terumo was founded in 1921 with the aim of producing of high-quality thermometers in Japan, to secure an important foundation of public health there. Since then, we have worked to rapidly bring medical settings the advanced products that they need, based on our unchanging group mission of "Contributing to Society through Healthcare." Because of our strong desire to contribute to the advancement of healthcare—not only in Japan, but throughout the world—we have taken on the challenges of a variety of clinical environment to now do business in over 160 countries and regions.

In 2021, Terumo will celebrate the 100th anniversary of its founding. To keep providing products and services of value to medical settings for the next 100 years, we will further enhance our overall Group strengths, beyond the boundaries of businesses, regions, and functions. Terumo Group instituted a new Terumo Group Identity in April 2019. This includes Core Values that are shared by Terumo Group to connect every Terumo associate throughout the world, and The Terumo Group Code of Conduct, which sets the highest ethical and behavioral standards across the Group.

Based on this new Group Identity, we will continue to do business in a way that fits the Terumo purpose, never forgetting our spirit of taking on challenges, even in the "Post-COVID" world.

We ask for your continued understanding and support in this endeavor.